Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Naphthoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A1 | P22736 | 1/20 | 0.95 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.95 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.95 |
| ▸ | CDC25B | P30305 | 2/20 | 0.74 |
| ▸ | WDR5 | P61964 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.60 |
| ▸ | LDHA | P00338 | 1/20 | 0.59 |
| ▸ | MMP3 | P08254 | 1/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.59 |
| ▸ | PLK1 | P53350 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Naphthoic Acid SCHEMBL29352220 | 0.98 | NR4A1 (1.00) | NR4A1NR4A2NR4A3CDC25BWDR5 | |
| Naphthoic Acid SCHEMBL28110155 | 0.98 | NR4A1 (1.00) | NR4A1NR4A2NR4A3CDC25BWDR5 | |
| Naphthoic Acid SCHEMBL30233567 | 0.98 | NR4A1 (1.00) | NR4A1NR4A2NR4A3CDC25BWDR5 | |
| Naphthoic Acid SCHEMBL17258 | 0.98 | NR4A1 (1.00) | NR4A1NR4A2NR4A3CDC25BWDR5 | |
| Naphthoic Acid SCHEMBL6912565 | 0.95 | NR4A1 (0.95) | NR4A1NR4A2NR4A3CDC25BWDR5 | |
| Naphthoic Acid SCHEMBL785728 | 0.95 | NR4A1 (0.95) | NR4A1NR4A2NR4A3CDC25BWDR5 | |
| Naphthoic Acid SCHEMBL3823412 | 0.95 | NR4A1 (0.95) | NR4A1NR4A2NR4A3CDC25BWDR5 | |
| Naphthoic Acid SCHEMBL868482 | 0.95 | NR4A1 (0.95) | NR4A1NR4A2NR4A3CDC25BWDR5 | |
| Naphthoic Acid SCHEMBL20591191 | 0.95 | NR4A1 (0.95) | NR4A1NR4A2NR4A3CDC25BWDR5 | |
| Naphthoic Acid SCHEMBL9178942 | 0.95 | NR4A1 (0.95) | NR4A1NR4A2NR4A3CDC25BWDR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1923381-B1 | Hydrogenation process for high-purity naphthalenedicarboxylic acid | HYOSUNG CORP (KR) | 2011-03-09 | — | — | EP | claimed |
| US-20080119666-A1 | Hydrogenation process for high-purity naphthalenedicarboxylic acid | HYOSUNG CORPORATION (KR) | 2008-05-22 | — | — | US | claimed |
| EP-1923381-A1 | Hydrogenation process for high-purity naphthalenedicarboxylic acid | Hyosung Corporation (KR) | 2008-05-21 | — | — | EP | claimed |
| WO-2016202894-A1 | METHOD OF CONVERTING ALCOHOL TO HALIDE | UNIVERSITAET DES SAARLANDES (DE) | 2016-12-22 | — | — | WO | disclosed |
| CN-103833723-B | The manufacture method of cyclic sulfonic acid ester and intermediate thereof | 和光纯药工业株式会社 | 2016-08-17 | — | — | CN | disclosed |
| EP-2757102-B1 | Intermediate for producing a cyclic sulfonic acid ester | WAKO PURE CHEM IND LTD (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-8969591-B2 | Method for producing cyclic sulfonic acid ester and intermediate thereof | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-03-03 | — | — | US | disclosed |
| EP-2463281-B1 | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | WAKO PURE CHEM IND LTD (JP) | 2014-10-22 | — | — | EP | disclosed |
| EP-2757102-A1 | 1,3-propanesultone derivative useful in the preparation of a 1,3-propenesultone derivative | Wako Pure Chemical Industries, Ltd. (JP) | 2014-07-23 | — | — | EP | disclosed |
| CN-103833723-A | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | WAKO PURE CHEM IND LTD | 2014-06-04 | — | — | CN | disclosed |
| US-20140142324-A1 | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-05-22 | — | — | US | disclosed |
| CN-101182292-B | Hydrogenation process for high-purity naphthalenedicarboxylic acid | HYOSUNG CORP. (KR) | 2011-11-30 | — | — | CN | disclosed |
| EP-1923381-B1 | Hydrogenation process for high-purity naphthalenedicarboxylic acid | HYOSUNG CORP (KR) | 2011-03-09 | — | — | EP | disclosed |
| JP-2008127383-A | HYDROGENATION PROCESS FOR 2,6-NAPHTHALENEDICARBOXYLIC ACID | HYOSUNG CORP | 2008-06-05 | — | — | JP | disclosed |
| US-20080119666-A1 | Hydrogenation process for high-purity naphthalenedicarboxylic acid | HYOSUNG CORPORATION (KR) | 2008-05-22 | — | — | US | disclosed |
| US-20080119666-A1 | Hydrogenation process for high-purity naphthalenedicarboxylic acid | HYOSUNG CORPORATION (KR) | 2008-05-22 | — | — | US | disclosed |
| EP-1923381-A1 | Hydrogenation process for high-purity naphthalenedicarboxylic acid | Hyosung Corporation (KR) | 2008-05-21 | — | — | EP | disclosed |
| EP-1923381-A1 | Hydrogenation process for high-purity naphthalenedicarboxylic acid | Hyosung Corporation (KR) | 2008-05-21 | — | — | EP | disclosed |
| CN-101182292-A | Hydrogenation process for high-purity naphthalenedicarboxylic acid | HYOSUNG CORP (KR) | 2008-05-21 | — | — | CN | disclosed |
| US-4044002-A | ACYL BROMIDES AND A BROMINE SCAVENGER | ELI LILLY AND COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142324-A1 | METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF | STS, TST, SULT1A1 | NR4A1 2986/4885NR4A2 3589/4885NR4A3 3312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.